ChemoCentryx
Utility Patent Applications
Last updated:
List of all ChemoCentryx patents 72 in total
| Status | Patent |
|---|---|
Application | Utility: Aza-Aryl 1H-Pyrazol-yl Benzene Sulfonamides Filling date: 8 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: CXCR7 INHIBITORS FOR THE TREATMENT OF CANCER Filling date: 8 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: METHODS OF TREATING PANCREATIC CANCER Filling date: 8 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: CAPSULE FORMULATIONS Filling date: 8 Sep 2025 Issue date: 4 Jun 2020 |
Application | Utility: Heteroaryl Sulfonamides and CCR2/CCR9 Filling date: 8 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: INHIBITORS OF CXCR2 Filling date: 8 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: SUBSTITUTED TETRAHYDROPYRANS AS CCR2 MODULATORS Filling date: 8 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: SUBSTITUTED ANILINES AS CCR(4) ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: 2-OXINDOLE COMPOUNDS Filling date: 8 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING A COMBINATION THERAPY OF SMALL MOLECULE INHIBITORS OF C-C CHEMOKINE RECEPTOR TYPE 9 (CCR9) AND ANTI-ALPHA4BETA7 INTEGRIN BLOCKING ANTIBODIES Filling date: 8 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: CXCR7 ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: COMBINATION THERAPY USING C-C CHEMOKINE RECEPTOR 4 (CCR4) ANTAGONISTS AND ONE OR MORE IMMUNE CHECKPOINT INHIBITORS Filling date: 8 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: MACROCYCLIC IMMUNOMODULATORS Filling date: 8 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: MODULATORS OF CHEMOKINE RECEPTORS Filling date: 8 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: DOSING AND EFFECT OF C5a ANTAGONIST WITH ANCA-ASSOCIATED VASCULITIS Filling date: 8 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: METHODS OF TREATING PANCREATIC CANCER Filling date: 8 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: INDANE-AMINES AS PD-L1 ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: COMBINATION THERAPY USING A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1/PD-L1 INHIBITOR Filling date: 8 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: SOLUBLE C5aR ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: METHODS OF TREATING SOLID TUMORS WITH CCR2 ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 5 Sep 2019 |
Showing 50 to 72 of 72 patents.